Jay K. Trautman
Chief Executive Officer at Invenio Imaging, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cyrus Mozayeni | M | 49 |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Kevin M. Ulmer | M | - |
GenEncap, Inc.
 GenEncap, Inc. Medical SpecialtiesHealth Technology GenEncap, Inc. develops and commercializes DNA sequencing technology. It offers proprietary technologies and massively-parallel sanger sequencing. The company was founded by Kevin M. Ulmer on June 19, 2007 and is headquartered in Providence, RI. | 17 years |
| Christian Freudiger | M | - |
Invenio Imaging, Inc.
 Invenio Imaging, Inc. Hospital/Nursing ManagementHealth Services Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA. | - |
| Sunney Xie | M | - |
Invenio Imaging, Inc.
Invenio Imaging, Inc. Hospital/Nursing ManagementHealth Services Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA. | - |
| Jonathan Ross | M | - |
Photoswitch Therapeutics, Inc.
 Photoswitch Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA. | - |
| Richard Kramer | M | - |
Photoswitch Therapeutics, Inc.
Photoswitch Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA. | - |
| Ehud Isacoff | M | - |
Photoswitch Therapeutics, Inc.
Photoswitch Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA. | - |
| Andrew Blatz | M | - |
Photoswitch Therapeutics, Inc.
Photoswitch Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA. | - |
| TJ Jia | M | - |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Benjamin Yerxa | M | 58 |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Daniel Orringer | M | - |
Invenio Imaging, Inc.
Invenio Imaging, Inc. Hospital/Nursing ManagementHealth Services Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA. | - |
| Kevin Bitterman | M | 47 |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Soraya Bekkali | M | - |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Douglas Crawford | M | - |
Invenio Imaging, Inc.
Invenio Imaging, Inc. Hospital/Nursing ManagementHealth Services Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA. | - |
| Mary Newman | F | 65 |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Steven Tregay | M | - |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | - |
| Richard G. Horan | M | - |
GenEncap, Inc.
GenEncap, Inc. Medical SpecialtiesHealth Technology GenEncap, Inc. develops and commercializes DNA sequencing technology. It offers proprietary technologies and massively-parallel sanger sequencing. The company was founded by Kevin M. Ulmer on June 19, 2007 and is headquartered in Providence, RI. | - |
| Abraham Bassan | M | 39 |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Cragg | M | 68 | 17 years | |
| Denise M. Gilbert | M | 66 | 7 years | |
| Andrew Wolff | M | 69 | 19 years | |
| Michael Schmertzler | M | 72 | 7 years | |
| Charles Homcy | M | 75 | 5 years | |
| William J. Rutter | M | - | - | |
| Michael S. Rabson | M | 70 | 2 years | |
| Mark McDade | M | 69 | 4 years | |
| Karen S. Wright | F | 69 | 3 years | |
| Jeffrey Finer | M | - | 9 years | |
| John Mao | M | - | - | |
| Larry Mattheakis | M | 67 | 5 years | |
| Marjorie C. Wagman | F | - | - | |
| Sharon Barbari | F | 70 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 32 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jay K. Trautman
- Personal Network